Glucagon receptor activation may increase energy expenditure
Mounjaro ist ein einmal wchentlich subkutan zu verabreichendes Inkretinmimetikum zur Behandlung des Typ-2-Diabetes mellitus
doi: 10.3389/fnut.2026.1778473 Received 31 December 2025 Revised 09 March 2026 Accepted 26 March 2026 Published 28 April 2026 Volume 13 - 2026 Edited by Huanling Lai, Guangzhou National Laboratory, China Reviewed by Jiayi Zhou, University of North Carolina at Chapel Hill, United States Mairepaiti Halimulati, The University of Texas at Austin, United States Updates Copyright 2026 Sun, Sun, Nan, Wang, Sun, Shi, Yang and Wang
Lastly, a fourth study discovered that IGF-1 promoted the spread of specific types of breast cancer cells
Supports Muscle Recovery and Physical Performance
Risk Factors for Fungal Diseases